Advances in Colorectal Cancer Organoids for Precision Medicine
Author Information
Author(s): Zhang Yanan, Meng Ruoyu, Sha Dan, Gao Huiquan, Wang Shengxi, Zhou Jun, Wang Xiaoshan, Li Fuxia, Li Xinyu, Song Wei
Primary Institution: The First Clinical Medical College of Shandong University of Traditional Chinese Medicine
Hypothesis
Colorectal cancer organoids can enhance precision medicine by accurately modeling tumor characteristics and responses to treatment.
Conclusion
Colorectal cancer organoids provide a promising platform for personalized treatment strategies and drug development.
Supporting Evidence
- Organoids closely mimic the original tumor tissue and maintain stable phenotypic structures.
- Integration of single-cell technology enhances insights into tumor heterogeneity and treatment response.
- Patient-derived organoids can predict treatment responses and optimize personalized therapies.
Takeaway
Scientists are using tiny models of tumors called organoids to better understand and treat colorectal cancer, making treatments more personalized for each patient.
Methodology
The review discusses the evolution of colorectal cancer organoid technology, its applications in precision medicine, and the integration of single-cell technology.
Limitations
Organoids cannot fully replicate the complex in vivo environment, including interactions with the vascular and immune systems.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website